The state of ARFID treatment
Key insights and treatment outcomes
Although awareness of ARFID is increasing, there is still a long way to go. As the leading ARFID treatment provider in the U.S., Equip is proud to share insights and outcomes to raise the bar on ARFID care and guide the field toward a new gold standard.
Key takeaways from the report
Despite growing awareness, ARFID patients still face 3 unique barriers that delay treatment
There are a number of treatment options for ARFID, but a multidisciplinary approach using research-backed modalities is best
ARFID treatment is most effective when tailored to the unique needs of the patient and structured to include 4 distinct phases
Equip is the leading ARFID treatment provider in the U.S., and our recent peer-reviewed paper is the largest study to date examining treatment outcomes in ARFID patients
Equip ARFID patients see steady symptom reduction, reliable weight restoration, and significant improvement in co-occurring conditions
Explore Equip Academy
Learn more about eating disorders from industry experts and earn CE credits.
